OTS-167

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameOTS-167
Drug Alias NameOTS 167POOTS-167OTSSP167
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMaternal embryonic leucine zipper kinase inhibitors
TargetsMaternal embryonic leucine zipper kinase
Therapy Area/IndicationsSolid tumoursMyelodysplastic SyndromesNeoplasm Metastasis +[7] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustralia
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesOncotherapy Science, Inc
China Registration ClassN/A

Develop Information

Active CompaniesOncotherapy Science, Inc
Inactive CompaniesN/A
Active IndicationsBreast Neoplasms
Inactive IndicationsSolid tumoursMyelodysplastic SyndromesNeoplasm Metastasis +[6] 

Other Information

ATC CodeN/A
Related LinksN/A